Vaxcyte Inc.

NASDAQ: PCVX · Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT

Vaxcyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-463.93M -402.27M -223.49M -100.08M
Depreciation & Amortization
15.85M 10.17M 9.2M 3.46M
Stock-Based Compensation
84.82M 48.76M 23.65M 10.73M
Other Working Capital
-89.48M 70.09M 9.84M -24.54M
Other Non-Cash Items
-34.47M -34.77M 7.3M 1.5M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-54.9M 81.32M 12.74M -37.01M
Operating Cash Flow
-452.63M -296.79M -170.6M -121.39M
Capital Expenditures
-22.43M -67.88M -5.85M -6.55M
Cash Acquisitions
n/a n/a 7K 26K
Purchase of Investments
-3.09B -1.33B -102.75M -336.34M
Sales Maturities Of Investments
1.2B 624.46M 183.17M 130.56M
Other Investing Acitivies
-96.73M n/a 80.43K -205.75K
Investing Cash Flow
-2.01B -773.31M 74.58M -212.31M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-14.29M 3.77M 5.07M 3.9M
Financial Cash Flow
2.45B 639.81M 861.55M 17.8M
Net Cash Flow
-9.36M -436.97M 765.67M -316.34M
Free Cash Flow
-475.05M -364.67M -176.44M -127.95M